Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 16 | 17 | 17 | 19 | 15 |
| Accounts receivable | 17 | -29 | -6 | -12 | -9 |
| Other Working Capital | -133 | -50 | 113 | 272 | 182 |
| Other Operating Activity | -540 | -103 | -219 | -338 | -292 |
| Operating Cash Flow | $-639 | $-165 | $-95 | $-60 | $-104 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 27 | -27 | 0 |
| Investing Cash Flow | $N/A | $N/A | $27 | $-27 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,070 | 253 | 102 | 56 | 138 |
| Other Financing Activity | -30 | -2 | 0 | 0 | -4 |
| Financing Cash Flow | $1,040 | $251 | $102 | $55 | $135 |
| Beginning Cash Position | 128 | 41 | 8 | 31 | 4 |
| End Cash Position | 527 | 128 | 42 | 8 | 31 |
| Net Cash Flow | $401 | $86 | $34 | $-32 | $31 |
| Free Cash Flow | |||||
| Operating Cash Flow | -639 | -165 | -95 | -60 | -104 |
| Capital Expenditure | N/A | N/A | N/A | -27 | N/A |
| Free Cash Flow | -639 | -165 | -95 | -87 | -104 |